AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03204968 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vagus nerve stimulation
Description: transcutaneous Intermittent stimulation of the vagus nerve using neurostimulator V (Ducest®, Germany)
Study NCT02355197 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: L-ascorbic acid
Description: 1 gram L-ascorbic acid (vitamin C .....) per day from the time of diagnosis until the time of delivery
Study NCT01985789 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diphenhydramine
Study NCT01985789 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cetirizine
Study NCT01985789 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: desloratadine
Study NCT05253664 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Woman-Centered Care Group
Description: Each woman in the experimental group was given woman-centered care as from 2 hours postpartum and this process continued until 24 hours postpartum. Physiological parameters (systolic-diastolic blood pressure, pulse, body temperature) of women assigned either to the experimental group or the control group were measured at 2 hrs postpartum. The State, Trait Anxiety, and Postpartum Comfort Scales were pretested. A dynamic interaction was ensured between the researcher and the women in the experimental group who received woman-centered care. In the processes of determining and meeting the care needs of women in the early postpartum period, both the women and the researcher took equal responsibilities and the common goal of achieving safe results was shared. Clinical guidelines were used while providing woman-centered care.
Study NCT00186186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Depakote ER
Description: Depakote ER
Study NCT03319680 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Citrate dialysate
Description: Compare the effect of citrate dialysate with acetate dialysate
Study NCT00382681 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FID 107027 Multi-Purpose Disinfecting Solution
Description: Investigational, multi-purpose disinfecting solution intended for use in cleaning, rinsing, conditioning, disinfecting, and storing soft contact lenses.
Study NCT00382681 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ReNu MultiPlus Multi-Purpose Solution No Rub Formula
Description: Commercially marketed product indicated for cleaning, rinsing, disinfecting, and storing soft contact lenses.
Study NCT02349503 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NBI-77860
Study NCT05863481 — intervention group
Intervention type: PROCEDURE
Intervention: Laparoscopic cerclage placement
Description: The surgical method of the laparoscopic cerclage procedure at Aarhus University Hospital previous described in a paper by Riiskjaer et al (DOI: 10.1111/aogs.12001)
Study NCT01204255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lorazepam
Description: Given topically
Study NCT01204255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: diphenhydramine hydrochloride
Description: Given topically
Study NCT01204255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: haloperidol
Description: Given topically
Study NCT01204255 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaire administration
Description: Ancillary studies
Study NCT01204255 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT04359355 — intervention group
Intervention type: DEVICE
Intervention: Artificial Intelligence System for Detection of colorectal polyps
Description: In this group, an artificial Intelligence System will be used for computer-aided diagnosis of colorectal polyps. Diagnostic Performance of the artificial intelligence System for detection of polyps will be compared against Operator-based detection in the same group
Study NCT03925818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bismuth Subcitrate Potassium
Description: Pylera capsules
Study NCT03925818 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Gastrus
Description: Gastrus 1 tablet
Study NCT01985789 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study NCT04951531 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: BPTB double-bundle allograft
Description: The patient underwent surgery of arthroscopic double-bundle anterior cruciate ligament (ACL) reconstruction with bone-patellar tendon-bone (BPTB) allograft．
Study NCT04951531 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: BPTB single-bundle allograft group
Description: The patient underwent surgery of arthroscopic single-bundle anterior cruciate ligament (ACL) reconstruction with bone-patellar tendon-bone (BPTB) allograft．
Study NCT04951531 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: BPTB single-bundle autograft group
Description: The patient underwent surgery of arthroscopic single-bundle anterior cruciate ligament (ACL) reconstruction with bone-patellar tendon-bone (BPTB) autograft．
Study NCT02450825 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Lung ultrasound examination on Day 1 and Day 2 to 4
Description: A standardized lung ultrasound examination using the GE Vivid ultrasound system will be performed following the tomographic scan on Day 1 and repeated on Day 2 to 4. Correlation of ultrasound-based aeration scores will be done with lung aeration measured by computed tomographic images.
Study NCT02450825 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Lung ultrasound examination on Day 1
Description: A standardized lung ultrasound examination using the GE Vivid ultrasound system will be performed following the tomographic scan on Day 1 only. Correlation of ultrasound-based aeration scores will be done with lung aeration measured by computed tomographic images.
Study NCT02450825 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: GE Vivid Ultrasound system
Description: The GE Vivid ultrasound system will be used for all lung ultrasound examinations performed in this study.
Study NCT01738243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid Gel injection
Description: The conjunctiva is anesthetized with Proparacaine Hydrochloride Ophthalmic Solution, 0.5%. The upper eyelid is everted and the conjunctiva just superior to the upper tarsal edge is exposed. Using a 30-gauge needle, a single bolus of Hyaluronic Acid Gel is placed centrally in the subconjunctival levator-Muller plane. Small volumes (0.1 to 0.2 ml) of Hyaluronic Acid Gel are injected with the end point being adequate lowering with improved symmetry.
Study NCT01738243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saline injection
Description: The conjunctiva is anesthetized with Proparacaine Hydrochloride Ophthalmic Solution, 0.5%. The upper eyelid is everted and the conjunctiva just superior to the upper tarsal edge is exposed. Using a 30-gauge needle, a single bolus of saline is placed centrally in the subconjunctival levator-Muller plane. Small volumes (0.1 to 0.2 ml) of saline are injected with the end point being adequate lowering with improved symmetry.
Study NCT00987350 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LectraJet
Description: LectraJet is a new jet injector studied for the first time in humans. It is in the category known as disposable-syringe jet injectors that have the advantage of eliminating the risk of disease transmission between subjects. A new syringe and nozzle is used for each patient so that no splash back of blood can occur onto the jet apparatus itself.
Study NCT00987350 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TIV by jet injection
Description: Administration of seasonal trivalent influenza vaccine (TIV) by jet injection
Study NCT00987350 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Seasonal Trivalent Influenza Vaccine
Description: Licensed trivalent influenza vaccine provided by either jet injection or traditional needle and syringe.
Study NCT02819115 — intervention group
Intervention type: BIOLOGICAL
Intervention: Butantan Fragmented Inactivated Trivalent Influenza Vaccine
Description: Butantan Fragmented Inactivated Trivalent Influenza Vaccine
Study NCT01670214 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pulsed electromagnetic field
Description: parameters of the pulsed electromagnetic field are frequency:10 Hz, intensity 4-5 mT, 6 sessions( 2 week) for placebo and phase 1 treatment ( 3 sessions in week) and added 6 sessions for phase 2 treatment. the solenoid diameter of instrument is 70 cm is placed around the head.
Study NCT01670214 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: pulsed electromagnetic field
Description: parameters of the pulsed electromagnetic field are frequency:10 Hz, intensity 4-5 mT, 6 sessions( 2 week) for placebo and phase 1 treatment ( 3 sessions in week) and added 6 sessions for phase 2 treatment. the solenoid diameter of instrument is 70 cm is placed around the head.
Study NCT03134508 — intervention group
Intervention type: OTHER
Intervention: treated by antiTNFα
Description: pregnant IBD women treated by antiTNFα
Study NCT03134508 — intervention group
Intervention type: OTHER
Intervention: not treated by antiTNFα
Description: pregnant IBD women not treated by antiTNFα
Study NCT04161274 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional method: Electrosurgery
Description: The patient will be prepared before this technique by removing all metal objects in his possession. The area should be disinfected with a local antiseptic, leaving the area aseptic. Afterwards, perilesional infiltrated local anaesthesia (subcutaneous or intradermal) will be applied. Once the area has been anaesthetised, excision is made with scissors cutting through the most proximal part of the skin tag pendulum and the lesion is coagulated with the handle or knife of the electrocoagulator (previously regulated with the intensity in coagulation mode). The resulting abrasion will form an eschar that will be disinfected with povidone-iodine, and a protective dressing of sterile occlusive gauze bandage will be placed.~Indications to the patient: the project participant will be instructed to dry the area with povidone-iodine antiseptic and not to expose the area to extreme humidity or sunlight.
Study NCT04161274 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional method: Cryotherapy
Description: The patient should be prepared: the area should be disinfected with a local antiseptic, leaving the area aseptic. for a few minutes the tip of an Adson forceps will be introduced in a container with liquid nitrogen until freezing. It will then be applied to the most proximal part of the skin tag pendulum until it is observed that the frostbite has reached the base of the lesion and the surface becomes whitish, with a halo of 1-3 mm. When this happens, it will be excise above the frost part in the pendulum. After application, it is disinfected with povidone- iodine and covered with a protective dressing of sterile occlusive gauze plaster. It will then form an eschar. Indications to the patient: the project participant will be instructed to dry the area with povidone-iodine antiseptic and not to expose the area to extreme humidity or sunlight.
Study NCT04161274 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional method: Silver nitrate
Description: The patient should be prepared: the area should be disinfected with a local antiseptic, leaving the area aseptic. Excision will be made with scissors of the skin tag cutting through the most proximal part of the skin tag pendulum, then cauterized with the tip of the silver nitrate rod, trying not to apply in the perilesional zone.~The resulting abrasion will form an eschar that will be disinfected with povidone-iodine, and a protective dressing of sterile occlusive gauze bandage will be placed.~Indications to the patient: the project participant will be instructed to dry the area with povidone-iodine antiseptic and not to expose the area to extreme humidity or solar rays.
Study NCT04161274 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Moist healing environment method
Description: The patient should be prepared: the area should be disinfected with a local antiseptic, leaving the area aseptic. Excision will be made with scissors of the skin tag by cutting through the most proximal part of the pendulum of the skin tag, later it will be disinfected with chlorhexidine and thin hydrocolloid dressing will be placed. Indications to the patient: the project participant will be told not to touch the dressing until the next control after 3 days with the research team. In case of incidents with the dressing (fall of the dressing), the patient will be given a replacement dressing for this purpose and be able to restore it immediately. It is recommended not to expose the area to the solar rays
Study NCT04748406 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Extracorporeal Shock Wave Therapy(ESWT)
Description: Group 2 (n = 35) will be applied 1 session per week for 3 weeks, 3 sessions of ESWT (1.8 bar, 10.0 Hz, 2000 beats) + cold application + home exercise program will be applied.
Study NCT04748406 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Peloid therapy
Description: Group 1 (n = 35) will be given 15 sessions of peloid therapy + cold application + home exercise program for 3 weeks, 5 days a week
Study NCT04748406 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home Workout Program
Description: Patients will be given a home exercise program consisting of eccentric strengthening exercises and stretching exercises, which are planned to increase resistance every week. The patients will be taught strengthening exercises for forearm pronation-supination with wrist extensors and a home exercise program will be started 3 sets of 10 repetitions per day.
Study NCT04748406 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cold application
Description: At the beginning of each treatment, gel ice packs are wrapped with a moist towel and placed around the elbow joint for 15 minutes. will be applied.
Study NCT02417909 — intervention group
Intervention type: OTHER
Intervention: questionnaires about quality of life
Description: all teenagers included in the trial and their parents must complete the questionnaires given of them the day of enrollment.
Study NCT02430428 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Carl Zeiss Meditec VisuMax Femtosecond Laser
Description: VisuMax femtosecond laser sphere-only or spherocylindrical treatment
Study NCT01699620 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: BAHA implant insertion
Description: The intervention is insertion of the Cochlear Bi300 to be used for bone anchored hearing aid.
Study NCT04012944 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cordella™ Pulmonary Artery Sensor System
Description: The Cordella PA Sensor System comprises seven subsystems that operate together to take daily Pulmonary Artery Pressure (PAP) readings at a patient's home and transmit the results to a care provider for evaluation.~1. Cordella Sensor~2. Cordella Delivery System~3. myCordella Patient Reader~4. Reader Dock~5. Cordella Calibration Equipment (CalEQ)~6. myCordella Hub~7. Cordella Data Analysis Platform (CDAP).
Study NCT01094730 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: galyfilcon A prototype lens
Description: Experimental silicone hydrogel contact lens
Study NCT01094730 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: marketed galyfilcon A lens
Description: Marketed silicone hydrogel contact lens.
Study NCT03196310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platelet Concentrate
Description: Platelet Rich plasma
Study NCT03196310 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid injection
Description: Kenalog
Study NCT00674830 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: professionally administered cognitive-behavioral therapy
Description: professionally administered CBT-I consisting of six weekly sessions
Study NCT00674830 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: self-administered form of cognitive-behavioral therapy
Description: self-administered CBT-I consisting of six short booklets and videotapes
Study NCT00674830 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: usual care
Study NCT02492997 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Venus Versa
Description: The Venus Versa system is a console that supports an applicators that simultaneously emits radio frequency (RF) and a Pulsed Magnetic Field (PEMF). This combination of energy can raise the temperature of treatment area quickly and homogeneously. The Pulsed Magnetic Field is induced by short pulses of electrical current through coil in the applicator. The magnetic field penetrates into the skin and results in Foucault (Eddy) electrical currents around the cell membranes of the treated tissues. Foucault currents change the electrical potential of charged receptors on the bi-lipid cell membrane layer of dermal cells, which results in the stimulation of molecular and cellular activities and reactions.
Study NCT02492997 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Venus Versa
Description: The Venus Versa system is a console that supports an applicators that simultaneously emits radio frequency (RF) and a Pulsed Magnetic Field (PEMF). This combination of energy can raise the temperature of treatment area quickly and homogeneously. The Pulsed Magnetic Field is induced by short pulses of electrical current through coil in the applicator. The magnetic field penetrates into the skin and results in Foucault (Eddy) electrical currents around the cell membranes of the treated tissues. Foucault currents change the electrical potential of charged receptors on the bi-lipid cell membrane layer of dermal cells, which results in the stimulation of molecular and cellular activities and reactions.
Study NCT02492997 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Glycerine gel
Description: Gel used to protect the skin from the RF energy and to assist with energy distribution
Study NCT02492997 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glycerine gel
Description: Gel used to protect the skin from the RF energy and to assist with energy distribution
Study NCT04362449 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Shortened hydration time and dispensary of Akynzeo
Description: Hydration is reduced to 1 hour and 40 minutes and Akynzeo is administered as an oral drug instead of Ondansetron being given as an IV before chemotherapy.
Study NCT04362449 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Hydration remains at around 6 hours and 30 minutes due to no oral fluids being consumed prior to treatment and normal saline being administered for 90 minutes before cisplatin and then for 2 hours after cisplatin and before gemcitabine administration
Study NCT03783052 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: SmartPill in fasted state
Description: SmartPill administration in fasted state
Study NCT03783052 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: SmartPill in fed state
Description: SmartPill administration in fed state
Study NCT03783052 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Aspiration
Description: Aspiration of gastrointestinal samples in fasted and fed state
Study NCT03438539 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Normative Feedback
Description: Subjects assigned to normative feedback will be directed to a statement standardized based on subjects' reported average number of standard drinks per week, age, and gender.
Study NCT03438539 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inhibitory Control Training
Description: The inhibitory control training task is a modified version of the Cued Go/No-Go tasks (Weafer and Fillmore, 2012; Miller et al. 1991) and is based on a task currently used in our laboratory targeting cocaine inhibitory control.
Study NCT03783052 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Gastric emptying scintigraphy
Description: Gastric emptying scintigraphy in fed state
Study NCT01880502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belviq 10mg
Description: Belviq 10mg single dose administration
Study NCT01880502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belviq 20mg
Description: Belviq 20mg single dose administration
Study NCT01880502 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo single dose administration
Study NCT01577368 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Piperacillin-Tazobactam continuous infusion
Description: Piperacillin-Tazobactam 2gr (Loading dose DAY 1) plus Piperacillin-Tazobactam continuous infusion 8gr every 24 hours (DAY 1-14)
Study NCT03196310 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: Control Group - Placebo
Study NCT03438539 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Working Memory Training
Description: A battery of working memory tasks will be used during the intervention period. These tasks were selected from previous research evaluating working memory training in substance use disorder (Bickel et al., 2011b; Houben et al., 2011b). Tasks will include visuospatial working memory task, digit span task, letter span task, and the n-back task.
Study NCT01025674 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Action program
Description: Components of the Positive Action program (6 units) use research-supported educational strategies/methods that include active learning, positive classroom management, teacher training, detailed curriculum with almost daily lessons, school-wide climate-change program, and family program of parent support/involvement.
Study NCT03131622 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Therapeutics